Skip to main content
. 2020 Jun 3;16:1391–1398. doi: 10.2147/NDT.S239504

Figure 1.

Figure 1

Model of targeting of CRMPs by maternal autoantibodies in MAR ASD. (A) Maternal autoantibodies targeting CRMPs readily pass placenta and (B) the undeveloped blood-brain barrier of the fetus. (C) The antibodies are internalized into neurons, bind and inactivate CRMPs resulting in changes in neural development.